FINWIRES · TerminalLIVE
FINWIRES

Mayne Pharma Group Receives AU$14.4 Million from Cosette Pharmaceuticals for Legal Costs

By

Mayne Pharma Group (ASX:MYX) confirmed that it received AU$14.4 million from Cosette Pharmaceuticals in accordance with the Supreme Court of New South Wales' orders, comprising recovery of Mayne's legal costs, costs associated with Mayne's application for costs, and interest, according to a Friday Australian bourse filing.

The company began proceedings against Cosette in June 2025 in relation to Cosette's purported termination of the scheme implementation deed signed by the two parties in February 2025. The court ruled in favor of the company in October 2025 and made an adverse costs order against Cosette.

An appeal against the October 2025 judgment by Cosette was heard in the Supreme Court of New South Wales, Court of Appeal on Tuesday and Wednesday, and a decision was reserved.

Its shares rose over 1% in recent trading on Friday.

Related Articles

Asia

Air Water Declares Lower Final Dividend for Fiscal 2025

Air Water (TYO:4088) declared a year-end dividend of 37.50 yen per share for the fiscal year 2025, matching earlier forecasts and lower than the 43 yen per share paid a year ago.The total dividend payment amounts to nearly 8.60 billion yen, payable from retained earnings on June 30, according to a Tokyo bourse filing on Thursday.

$TYO:4088
Asia

Kingston Resources Requests Further Extension to Voluntary Suspension of Securities

Kingston Resources (ASX:KSN) requested a further extension to the voluntary suspension of its securities, which was granted on Wednesday, as it continues to assess the impact of the pit wall failure affecting the Pearse South ramp at the Mineral Hill mine in New South Wales, according to a Friday Australian bourse filing.It said it was unable to provide a detailed and informed update to the market, and the firm requested that the suspension remain in place until the earlier of Kingston providing an update to the market or the start of trading on June 11.

$ASX:KSN
Asia

American Tungsten Extends Known Mineralization at Utah Prospect; Shares Fall 8%

American Tungsten & Antimony's (ASX:AT4) phase one diamond drilling program at the Antimony Canyon project in Utah extended the known high-grade mineralized envelope at the Little Emma prospect and confirmed the presence of a district-scale hydrothermal antimony system, according to a Friday Australian bourse filing.It encountered intercepts of 10.37 meters at 3.98% grade of antimony from 3.35 meters, as well as 5.7 meters at 2.8% grade of antimony from 48.68 meters.,Its shares fell over 8% in recent trading on Friday, reaching their lowest point in over a year.

$ASX:AT4